COVID-19 Impact on Global Infantile Spasm Treatment Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/covid-19-impact-on-global-infantile-spasm-treatment-market-size-status-n-forecast-2020-2026_en.gif)
This report focuses on the global Infantile Spasm Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Infantile Spasm Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- Mallinckrodt
- H. Lundbeck
- Insys Therapeutics
- Orphelia Pharma
- Valerion Therapeutics
- Catalyst Pharmaceuticals
- Anavex Life Sciences
- Retrophin
- GW Pharmaceuticals
- Oral
- Parenteral
- Hospital
- Clinic
- Other
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global Infantile Spasm Treatment status, future forecast, growth opportunity, key market and key players.
- To present the Infantile Spasm Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Infantile Spasm Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Infantile Spasm Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Parenteral
1.5 Market by Application
1.5.1 Global Infantile Spasm Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Infantile Spasm Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Infantile Spasm Treatment Industry
1.6.1.1 Infantile Spasm Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Infantile Spasm Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Infantile Spasm Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Infantile Spasm Treatment Market Perspective (2015-2026)
2.2 Infantile Spasm Treatment Growth Trends by Regions
2.2.1 Infantile Spasm Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Infantile Spasm Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Infantile Spasm Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Infantile Spasm Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Infantile Spasm Treatment Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Infantile Spasm Treatment Players by Market Size
3.1.1 Global Top Infantile Spasm Treatment Players by Revenue (2015-2020)
3.1.2 Global Infantile Spasm Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Infantile Spasm Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Infantile Spasm Treatment Market Concentration Ratio
3.2.1 Global Infantile Spasm Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Infantile Spasm Treatment Revenue in 2019
3.3 Infantile Spasm Treatment Key Players Head office and Area Served
3.4 Key Players Infantile Spasm Treatment Product Solution and Service
3.5 Date of Enter into Infantile Spasm Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Infantile Spasm Treatment Historic Market Size by Type (2015-2020)
4.2 Global Infantile Spasm Treatment Forecasted Market Size by Type (2021-2026)
5 INFANTILE SPASM TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Infantile Spasm Treatment Market Size by Application (2015-2020)
5.2 Global Infantile Spasm Treatment Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Infantile Spasm Treatment Market Size (2015-2020)
6.2 Infantile Spasm Treatment Key Players in North America (2019-2020)
6.3 North America Infantile Spasm Treatment Market Size by Type (2015-2020)
6.4 North America Infantile Spasm Treatment Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Infantile Spasm Treatment Market Size (2015-2020)
7.2 Infantile Spasm Treatment Key Players in Europe (2019-2020)
7.3 Europe Infantile Spasm Treatment Market Size by Type (2015-2020)
7.4 Europe Infantile Spasm Treatment Market Size by Application (2015-2020)
8 CHINA
8.1 China Infantile Spasm Treatment Market Size (2015-2020)
8.2 Infantile Spasm Treatment Key Players in China (2019-2020)
8.3 China Infantile Spasm Treatment Market Size by Type (2015-2020)
8.4 China Infantile Spasm Treatment Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Infantile Spasm Treatment Market Size (2015-2020)
9.2 Infantile Spasm Treatment Key Players in Japan (2019-2020)
9.3 Japan Infantile Spasm Treatment Market Size by Type (2015-2020)
9.4 Japan Infantile Spasm Treatment Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Infantile Spasm Treatment Market Size (2015-2020)
10.2 Infantile Spasm Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Infantile Spasm Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Infantile Spasm Treatment Market Size by Application (2015-2020)
11 INDIA
11.1 India Infantile Spasm Treatment Market Size (2015-2020)
11.2 Infantile Spasm Treatment Key Players in India (2019-2020)
11.3 India Infantile Spasm Treatment Market Size by Type (2015-2020)
11.4 India Infantile Spasm Treatment Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Infantile Spasm Treatment Market Size (2015-2020)
12.2 Infantile Spasm Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Infantile Spasm Treatment Market Size by Type (2015-2020)
12.4 Central & South America Infantile Spasm Treatment Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Mallinckrodt
13.1.1 Mallinckrodt Company Details
13.1.2 Mallinckrodt Business Overview and Its Total Revenue
13.1.3 Mallinckrodt Infantile Spasm Treatment Introduction
13.1.4 Mallinckrodt Revenue in Infantile Spasm Treatment Business (2015-2020))
13.1.5 Mallinckrodt Recent Development
13.2 H. Lundbeck
13.2.1 H. Lundbeck Company Details
13.2.2 H. Lundbeck Business Overview and Its Total Revenue
13.2.3 H. Lundbeck Infantile Spasm Treatment Introduction
13.2.4 H. Lundbeck Revenue in Infantile Spasm Treatment Business (2015-2020)
13.2.5 H. Lundbeck Recent Development
13.3 Insys Therapeutics
13.3.1 Insys Therapeutics Company Details
13.3.2 Insys Therapeutics Business Overview and Its Total Revenue
13.3.3 Insys Therapeutics Infantile Spasm Treatment Introduction
13.3.4 Insys Therapeutics Revenue in Infantile Spasm Treatment Business (2015-2020)
13.3.5 Insys Therapeutics Recent Development
13.4 Orphelia Pharma
13.4.1 Orphelia Pharma Company Details
13.4.2 Orphelia Pharma Business Overview and Its Total Revenue
13.4.3 Orphelia Pharma Infantile Spasm Treatment Introduction
13.4.4 Orphelia Pharma Revenue in Infantile Spasm Treatment Business (2015-2020)
13.4.5 Orphelia Pharma Recent Development
13.5 Valerion Therapeutics
13.5.1 Valerion Therapeutics Company Details
13.5.2 Valerion Therapeutics Business Overview and Its Total Revenue
13.5.3 Valerion Therapeutics Infantile Spasm Treatment Introduction
13.5.4 Valerion Therapeutics Revenue in Infantile Spasm Treatment Business (2015-2020)
13.5.5 Valerion Therapeutics Recent Development
13.6 Catalyst Pharmaceuticals
13.6.1 Catalyst Pharmaceuticals Company Details
13.6.2 Catalyst Pharmaceuticals Business Overview and Its Total Revenue
13.6.3 Catalyst Pharmaceuticals Infantile Spasm Treatment Introduction
13.6.4 Catalyst Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2015-2020)
13.6.5 Catalyst Pharmaceuticals Recent Development
13.7 Anavex Life Sciences
13.7.1 Anavex Life Sciences Company Details
13.7.2 Anavex Life Sciences Business Overview and Its Total Revenue
13.7.3 Anavex Life Sciences Infantile Spasm Treatment Introduction
13.7.4 Anavex Life Sciences Revenue in Infantile Spasm Treatment Business (2015-2020)
13.7.5 Anavex Life Sciences Recent Development
13.8 Retrophin
13.8.1 Retrophin Company Details
13.8.2 Retrophin Business Overview and Its Total Revenue
13.8.3 Retrophin Infantile Spasm Treatment Introduction
13.8.4 Retrophin Revenue in Infantile Spasm Treatment Business (2015-2020)
13.8.5 Retrophin Recent Development
13.9 GW Pharmaceuticals
13.9.1 GW Pharmaceuticals Company Details
13.9.2 GW Pharmaceuticals Business Overview and Its Total Revenue
13.9.3 GW Pharmaceuticals Infantile Spasm Treatment Introduction
13.9.4 GW Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2015-2020)
13.9.5 GW Pharmaceuticals Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Infantile Spasm Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Infantile Spasm Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Parenteral
1.5 Market by Application
1.5.1 Global Infantile Spasm Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Infantile Spasm Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Infantile Spasm Treatment Industry
1.6.1.1 Infantile Spasm Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Infantile Spasm Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Infantile Spasm Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Infantile Spasm Treatment Market Perspective (2015-2026)
2.2 Infantile Spasm Treatment Growth Trends by Regions
2.2.1 Infantile Spasm Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Infantile Spasm Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Infantile Spasm Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Infantile Spasm Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Infantile Spasm Treatment Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Infantile Spasm Treatment Players by Market Size
3.1.1 Global Top Infantile Spasm Treatment Players by Revenue (2015-2020)
3.1.2 Global Infantile Spasm Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Infantile Spasm Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Infantile Spasm Treatment Market Concentration Ratio
3.2.1 Global Infantile Spasm Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Infantile Spasm Treatment Revenue in 2019
3.3 Infantile Spasm Treatment Key Players Head office and Area Served
3.4 Key Players Infantile Spasm Treatment Product Solution and Service
3.5 Date of Enter into Infantile Spasm Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Infantile Spasm Treatment Historic Market Size by Type (2015-2020)
4.2 Global Infantile Spasm Treatment Forecasted Market Size by Type (2021-2026)
5 INFANTILE SPASM TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Infantile Spasm Treatment Market Size by Application (2015-2020)
5.2 Global Infantile Spasm Treatment Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Infantile Spasm Treatment Market Size (2015-2020)
6.2 Infantile Spasm Treatment Key Players in North America (2019-2020)
6.3 North America Infantile Spasm Treatment Market Size by Type (2015-2020)
6.4 North America Infantile Spasm Treatment Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Infantile Spasm Treatment Market Size (2015-2020)
7.2 Infantile Spasm Treatment Key Players in Europe (2019-2020)
7.3 Europe Infantile Spasm Treatment Market Size by Type (2015-2020)
7.4 Europe Infantile Spasm Treatment Market Size by Application (2015-2020)
8 CHINA
8.1 China Infantile Spasm Treatment Market Size (2015-2020)
8.2 Infantile Spasm Treatment Key Players in China (2019-2020)
8.3 China Infantile Spasm Treatment Market Size by Type (2015-2020)
8.4 China Infantile Spasm Treatment Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Infantile Spasm Treatment Market Size (2015-2020)
9.2 Infantile Spasm Treatment Key Players in Japan (2019-2020)
9.3 Japan Infantile Spasm Treatment Market Size by Type (2015-2020)
9.4 Japan Infantile Spasm Treatment Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Infantile Spasm Treatment Market Size (2015-2020)
10.2 Infantile Spasm Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Infantile Spasm Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Infantile Spasm Treatment Market Size by Application (2015-2020)
11 INDIA
11.1 India Infantile Spasm Treatment Market Size (2015-2020)
11.2 Infantile Spasm Treatment Key Players in India (2019-2020)
11.3 India Infantile Spasm Treatment Market Size by Type (2015-2020)
11.4 India Infantile Spasm Treatment Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Infantile Spasm Treatment Market Size (2015-2020)
12.2 Infantile Spasm Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Infantile Spasm Treatment Market Size by Type (2015-2020)
12.4 Central & South America Infantile Spasm Treatment Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Mallinckrodt
13.1.1 Mallinckrodt Company Details
13.1.2 Mallinckrodt Business Overview and Its Total Revenue
13.1.3 Mallinckrodt Infantile Spasm Treatment Introduction
13.1.4 Mallinckrodt Revenue in Infantile Spasm Treatment Business (2015-2020))
13.1.5 Mallinckrodt Recent Development
13.2 H. Lundbeck
13.2.1 H. Lundbeck Company Details
13.2.2 H. Lundbeck Business Overview and Its Total Revenue
13.2.3 H. Lundbeck Infantile Spasm Treatment Introduction
13.2.4 H. Lundbeck Revenue in Infantile Spasm Treatment Business (2015-2020)
13.2.5 H. Lundbeck Recent Development
13.3 Insys Therapeutics
13.3.1 Insys Therapeutics Company Details
13.3.2 Insys Therapeutics Business Overview and Its Total Revenue
13.3.3 Insys Therapeutics Infantile Spasm Treatment Introduction
13.3.4 Insys Therapeutics Revenue in Infantile Spasm Treatment Business (2015-2020)
13.3.5 Insys Therapeutics Recent Development
13.4 Orphelia Pharma
13.4.1 Orphelia Pharma Company Details
13.4.2 Orphelia Pharma Business Overview and Its Total Revenue
13.4.3 Orphelia Pharma Infantile Spasm Treatment Introduction
13.4.4 Orphelia Pharma Revenue in Infantile Spasm Treatment Business (2015-2020)
13.4.5 Orphelia Pharma Recent Development
13.5 Valerion Therapeutics
13.5.1 Valerion Therapeutics Company Details
13.5.2 Valerion Therapeutics Business Overview and Its Total Revenue
13.5.3 Valerion Therapeutics Infantile Spasm Treatment Introduction
13.5.4 Valerion Therapeutics Revenue in Infantile Spasm Treatment Business (2015-2020)
13.5.5 Valerion Therapeutics Recent Development
13.6 Catalyst Pharmaceuticals
13.6.1 Catalyst Pharmaceuticals Company Details
13.6.2 Catalyst Pharmaceuticals Business Overview and Its Total Revenue
13.6.3 Catalyst Pharmaceuticals Infantile Spasm Treatment Introduction
13.6.4 Catalyst Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2015-2020)
13.6.5 Catalyst Pharmaceuticals Recent Development
13.7 Anavex Life Sciences
13.7.1 Anavex Life Sciences Company Details
13.7.2 Anavex Life Sciences Business Overview and Its Total Revenue
13.7.3 Anavex Life Sciences Infantile Spasm Treatment Introduction
13.7.4 Anavex Life Sciences Revenue in Infantile Spasm Treatment Business (2015-2020)
13.7.5 Anavex Life Sciences Recent Development
13.8 Retrophin
13.8.1 Retrophin Company Details
13.8.2 Retrophin Business Overview and Its Total Revenue
13.8.3 Retrophin Infantile Spasm Treatment Introduction
13.8.4 Retrophin Revenue in Infantile Spasm Treatment Business (2015-2020)
13.8.5 Retrophin Recent Development
13.9 GW Pharmaceuticals
13.9.1 GW Pharmaceuticals Company Details
13.9.2 GW Pharmaceuticals Business Overview and Its Total Revenue
13.9.3 GW Pharmaceuticals Infantile Spasm Treatment Introduction
13.9.4 GW Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2015-2020)
13.9.5 GW Pharmaceuticals Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Infantile Spasm Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Infantile Spasm Treatment Revenue
Table 3. Ranking of Global Top Infantile Spasm Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Infantile Spasm Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Parenteral
Table 7. COVID-19 Impact Global Market: (Four Infantile Spasm Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Infantile Spasm Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Infantile Spasm Treatment Players to Combat Covid-19 Impact
Table 12. Global Infantile Spasm Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Infantile Spasm Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Infantile Spasm Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Infantile Spasm Treatment Market Share by Regions (2015-2020)
Table 16. Global Infantile Spasm Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Infantile Spasm Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Infantile Spasm Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Infantile Spasm Treatment Players
Table 23. Global Infantile Spasm Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Infantile Spasm Treatment Market Share by Players (2015-2020)
Table 25. Global Top Infantile Spasm Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infantile Spasm Treatment as of 2019)
Table 26. Global Infantile Spasm Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Infantile Spasm Treatment Product Solution and Service
Table 29. Date of Enter into Infantile Spasm Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Infantile Spasm Treatment Market Size Share by Type (2015-2020)
Table 33. Global Infantile Spasm Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Infantile Spasm Treatment Market Size Share by Application (2015-2020)
Table 35. Global Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Infantile Spasm Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 39. North America Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 41. North America Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 45. Europe Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 47. Europe Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 51. China Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 53. China Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 57. Japan Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 59. Japan Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 63. Southeast Asia Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 69. India Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 71. India Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 75. Central & South America Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 79. Mallinckrodt Company Details
Table 80. Mallinckrodt Business Overview
Table 81. Mallinckrodt Product
Table 82. Mallinckrodt Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 83. Mallinckrodt Recent Development
Table 84. H. Lundbeck Company Details
Table 85. H. Lundbeck Business Overview
Table 86. H. Lundbeck Product
Table 87. H. Lundbeck Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 88. H. Lundbeck Recent Development
Table 89. Insys Therapeutics Company Details
Table 90. Insys Therapeutics Business Overview
Table 91. Insys Therapeutics Product
Table 92. Insys Therapeutics Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 93. Insys Therapeutics Recent Development
Table 94. Orphelia Pharma Company Details
Table 95. Orphelia Pharma Business Overview
Table 96. Orphelia Pharma Product
Table 97. Orphelia Pharma Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 98. Orphelia Pharma Recent Development
Table 99. Valerion Therapeutics Company Details
Table 100. Valerion Therapeutics Business Overview
Table 101. Valerion Therapeutics Product
Table 102. Valerion Therapeutics Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 103. Valerion Therapeutics Recent Development
Table 104. Catalyst Pharmaceuticals Company Details
Table 105. Catalyst Pharmaceuticals Business Overview
Table 106. Catalyst Pharmaceuticals Product
Table 107. Catalyst Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 108. Catalyst Pharmaceuticals Recent Development
Table 109. Anavex Life Sciences Company Details
Table 110. Anavex Life Sciences Business Overview
Table 111. Anavex Life Sciences Product
Table 112. Anavex Life Sciences Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 113. Anavex Life Sciences Recent Development
Table 114. Retrophin Business Overview
Table 115. Retrophin Product
Table 116. Retrophin Company Details
Table 117. Retrophin Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 118. Retrophin Recent Development
Table 119. GW Pharmaceuticals Company Details
Table 120. GW Pharmaceuticals Business Overview
Table 121. GW Pharmaceuticals Product
Table 122. GW Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 123. GW Pharmaceuticals Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 1. Infantile Spasm Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Infantile Spasm Treatment Revenue
Table 3. Ranking of Global Top Infantile Spasm Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Infantile Spasm Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Parenteral
Table 7. COVID-19 Impact Global Market: (Four Infantile Spasm Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Infantile Spasm Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Infantile Spasm Treatment Players to Combat Covid-19 Impact
Table 12. Global Infantile Spasm Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Infantile Spasm Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Infantile Spasm Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Infantile Spasm Treatment Market Share by Regions (2015-2020)
Table 16. Global Infantile Spasm Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Infantile Spasm Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Infantile Spasm Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Infantile Spasm Treatment Players
Table 23. Global Infantile Spasm Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Infantile Spasm Treatment Market Share by Players (2015-2020)
Table 25. Global Top Infantile Spasm Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infantile Spasm Treatment as of 2019)
Table 26. Global Infantile Spasm Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Infantile Spasm Treatment Product Solution and Service
Table 29. Date of Enter into Infantile Spasm Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Infantile Spasm Treatment Market Size Share by Type (2015-2020)
Table 33. Global Infantile Spasm Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Infantile Spasm Treatment Market Size Share by Application (2015-2020)
Table 35. Global Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Infantile Spasm Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 39. North America Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 41. North America Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 45. Europe Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 47. Europe Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 51. China Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 53. China Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 57. Japan Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 59. Japan Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 63. Southeast Asia Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 69. India Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 71. India Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 75. Central & South America Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 79. Mallinckrodt Company Details
Table 80. Mallinckrodt Business Overview
Table 81. Mallinckrodt Product
Table 82. Mallinckrodt Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 83. Mallinckrodt Recent Development
Table 84. H. Lundbeck Company Details
Table 85. H. Lundbeck Business Overview
Table 86. H. Lundbeck Product
Table 87. H. Lundbeck Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 88. H. Lundbeck Recent Development
Table 89. Insys Therapeutics Company Details
Table 90. Insys Therapeutics Business Overview
Table 91. Insys Therapeutics Product
Table 92. Insys Therapeutics Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 93. Insys Therapeutics Recent Development
Table 94. Orphelia Pharma Company Details
Table 95. Orphelia Pharma Business Overview
Table 96. Orphelia Pharma Product
Table 97. Orphelia Pharma Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 98. Orphelia Pharma Recent Development
Table 99. Valerion Therapeutics Company Details
Table 100. Valerion Therapeutics Business Overview
Table 101. Valerion Therapeutics Product
Table 102. Valerion Therapeutics Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 103. Valerion Therapeutics Recent Development
Table 104. Catalyst Pharmaceuticals Company Details
Table 105. Catalyst Pharmaceuticals Business Overview
Table 106. Catalyst Pharmaceuticals Product
Table 107. Catalyst Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 108. Catalyst Pharmaceuticals Recent Development
Table 109. Anavex Life Sciences Company Details
Table 110. Anavex Life Sciences Business Overview
Table 111. Anavex Life Sciences Product
Table 112. Anavex Life Sciences Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 113. Anavex Life Sciences Recent Development
Table 114. Retrophin Business Overview
Table 115. Retrophin Product
Table 116. Retrophin Company Details
Table 117. Retrophin Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 118. Retrophin Recent Development
Table 119. GW Pharmaceuticals Company Details
Table 120. GW Pharmaceuticals Business Overview
Table 121. GW Pharmaceuticals Product
Table 122. GW Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 123. GW Pharmaceuticals Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Infantile Spasm Treatment Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Parenteral Features
Figure 4. Global Infantile Spasm Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Infantile Spasm Treatment Report Years Considered
Figure 9. Global Infantile Spasm Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Infantile Spasm Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Infantile Spasm Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Infantile Spasm Treatment Market Share by Players in 2019
Figure 14. Global Top Infantile Spasm Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infantile Spasm Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Infantile Spasm Treatment Revenue in 2019
Figure 16. North America Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Mallinckrodt Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 25. H. Lundbeck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. H. Lundbeck Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 27. Insys Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Insys Therapeutics Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 29. Orphelia Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Orphelia Pharma Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 31. Valerion Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Valerion Therapeutics Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 33. Catalyst Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Catalyst Pharmaceuticals Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 35. Anavex Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Anavex Life Sciences Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 37. Retrophin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Retrophin Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 39. GW Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. GW Pharmaceuticals Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
Figure 1. Global Infantile Spasm Treatment Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Parenteral Features
Figure 4. Global Infantile Spasm Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Infantile Spasm Treatment Report Years Considered
Figure 9. Global Infantile Spasm Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Infantile Spasm Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Infantile Spasm Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Infantile Spasm Treatment Market Share by Players in 2019
Figure 14. Global Top Infantile Spasm Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infantile Spasm Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Infantile Spasm Treatment Revenue in 2019
Figure 16. North America Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Mallinckrodt Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 25. H. Lundbeck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. H. Lundbeck Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 27. Insys Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Insys Therapeutics Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 29. Orphelia Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Orphelia Pharma Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 31. Valerion Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Valerion Therapeutics Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 33. Catalyst Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Catalyst Pharmaceuticals Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 35. Anavex Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Anavex Life Sciences Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 37. Retrophin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Retrophin Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 39. GW Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. GW Pharmaceuticals Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed